End-stage renal failure and management of diabetes

Diabetic Medicine, Supplement

Volumn 21, Issue 1, 2004, Pages 12-14

  Bilous, R W ^a  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN GLARGINE; ISOPHANE INSULIN; LOOP DIURETIC AGENT;

ADULT; ANOREXIA; ANTIHYPERTENSIVE THERAPY; BETA ADRENERGIC RECEPTOR BLOCKING; CASE REPORT; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DRUG INDICATION; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPERTENSION; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN RESISTANCE; INSULIN TREATMENT; KETOACIDOSIS; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; PATIENT CARE; PRACTICE GUIDELINE; REVIEW;

EID: 1542345555     PISSN: 14665468     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1466-5468.2004.1180f.x     Document Type: Review

References (14)

1. The Diabetes Control and Complications Trial research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-98 6.
2. Ramsay RC, Goetz FC, Sutherland DE, Mauer SM, Robison LL, Cantrill HL et al. Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med 1988; 318: 208-214.
3. McMurray SD, Johnson D, Davis S, McDougall K. Diabetes education and care management significantly improved patient outcomes in the dialysis unit. Am J Kid Dis 2002; 40: 566-575.
4. Kennedy WR, Navarro X, Goetz FC, Sutherland DE, Najarian JS. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 1990; 322: 1031-1037.
5. Schomig M, Ritz E, Standl E, Allenberg J. The diabetic foot and the dialysed patient. J Am Soc Nephrol 2000; 11: 1153-1159.
6. United States Renal Data System, Annual Data Report, Chapter 9, Survival, Mortality and Causes of Death. Bethesda, MD: National Institute of Health, 2002: 152-64
7. Morioka T, Emoto M, Tabata T, Shoji T, Tahara H, Kashimoto H et al. Glycemic control as a predictor of survival for diabetic patients on hemodialysis. Diabetes Care 2001; 24: 909-913.
8. Manske CL. Hyperglycemia and intensive glycemic control in diabetic patients with chronic renal disease. Am J Kid Dis 1998; 32: S157-171.
9. Ritz E, Mogensen CE, Cordonnier DJ. Renal failure due to diabetes mellitus. In Davison AM, Cameron JS, Grunfeld J-P, et al. eds. Oxford Textbook of Clinical Nephrology, 2nd edn. Oxford: Oxford University Press, 1998: 2273-2293.
10. National Institute for Clinical Excellence. Guidance on the Use of Continuous Subcutaneous Insulin Infusion for Diabetes. Technology appraisal guidance no. 57. London: NICE, 2003.
11. Kerr D. Drugs and alcohol. In Frier B, Fisher BM eds. Hypoglycaemia and Diabetes. Clinical and Physiological Aspect. London: Edward Arnold, 1993: 328-336.
12. Brennan GM, Morris AD. Coronary heart disease in patients with diabetes - pharmacological treatment in heart disease and diabetes. In Fisher M ed. Heart Disease and Diabetes. London: Martin Dunitz, 2003: 195-226.
13. Simic-Ogrizovic S, Backus G, Mayer A, Vienken J, Djukanovic L, Kleophas W. The influence of different glucose concentrations in haemodialysis solutions on metabolism and blood pressure stability in diabetic patients. Int J Art Organs 2001; 24: 863-869.
14. Suzuki Y, Arakawa M, Gajyo F, Collaborate Study Group. The treatment of the uraemic diabetic. Are we doing enough? A view from Japan. Nephrol Dial Transplant 1995; 10: 47-55.